Clinical Trial Update: Omalizumab Weight-Based Dosing Efficacy Trial [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating weight-based dosing of omalizumab for allergic conditions, including food allergy, which is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Diseases
• Food Allergy

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Allergies, Food Allergy | Phase 2 | Status: RECRUITING